https://www.selleckchem.com/products/stm2457.html
These suggest that USMC is a promising therapeutic modality for combining immune checkpoint blockade against solid tumors.Colorectal cancer (CRC) is one of the most common malignancies worldwide and is associated with poor prognosis and high mortality. Despite advances in treatment with chemotherapy, CRC remains a major cause of drug resistance-related cancer deaths. One of the main reasons for such resistance is dysregulation of Mcl-1 expression. In this study, we identified LZT-106 as a novel kinase inhibitor that was able to bind to
Like
Comment
Share
